Clinical Trial Details
| Trial ID: | L5826 |
| Source ID: | NCT00755833 |
| Associated Drug: | Biphasic Insulin Aspart 50 |
| Title: | Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes|Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: biphasic insulin aspart 50 |
| Outcome Measures: | Primary: Change in HbA1c, At 0, 3, 6, 9, 12 months | Secondary: Percentage of subjects achieving target HbA1c, At 0, 3, 6, 9, 12 months|Change in FPG (fasting plasma glucose), At 0, 3, 6, 9, 12 months|Change in PPG (postprandial glucose), At 0, 3, 6, 9, 12 months|Change in number of hypoglycaemic events, At 0, 3, 6, 9, 12 months|Change in insulin presentation, At 0, 3, 6, 9, 12 months|Dose and number of injections, At 0, 3, 6, 9, 12 months|Number of ADRs (adverse drug reaction), At 0, 3, 6, 9, 12 months |
| Sponsor/Collaborators: | Sponsor: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | CHILD, ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 270 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2008-09 |
| Completion Date: | 2010-04 |
| Results First Posted: | |
| Last Update Posted: | 2016-10-31 |
| Locations: | Novo Nordisk Investigational Site, Ljubljana, SI-1000, Slovenia |
| URL: | https://clinicaltrials.gov/show/NCT00755833 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|